BMY vs COR
Bristol Myers Squibb vs Cencora — AI-powered side-by-side comparison
| Metric | BMY | COR |
|---|---|---|
| AI Score | 55 | 55 |
| Price | $60.77 | $300.75 |
| P/E Ratio | 17.12× | 23.10× |
| ROE | 0.4% | 1.0% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.7% | 0.0% |
| Debt / Equity | 2.22× | 3.65× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 65.0 | 55.8 |
| Beta | 0.235 | 0.581 |
| Expected Upside | +0.2% | +2.0% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BMY Full Analysis
COR Full Analysis